Greater Glasgow and Clyde Medicines

MHRA Drug Safety Update for January 2022

• Seal-Tight ™ wound care protectors are included in the NHSGGC Wound formulary for use on chronic lower limb wounds
• They are not to be prescribed for patients who can remove compression hosiery or wound dressings and reapply independently after bathing or patients with fracture casts.

Adding “outside” medicines (those prescribed and supplied outside the practice) to patient prescriptions will result in:

• Safer prescribing: prescription record is complete allowing GP practice clinical decision support to flag drug interactions
• Increased patient safety: these medicines appear in the Emergency Care Summary (ECS)
• Improved medicines reconciliation: due to more complete record of prescribing in ECS

Guideline News December 2021

Key Medicine Shortages for December 2021

MHRA Drug Safety Update for December 2021

Ronapreve® is now indicated in two distinct patient populations:

Group 1: Patients admitted unwell with COVID-19 who are negative for baseline serum anti-spike (anti-S) antibodies against SARS-CoV-2.

Group 2: Patients with early hospital onset COVID-19 who are at high risk of progression to severe COVID-19 or in whom COVID-19 infection presents a material risk of destabilising a pre-existing condition or illness or compromising recovery from surgery or other hospital procedure.

Guideline News for November 2021

Antiretrovirals for the treatment of HIV in Acute.